Literature DB >> 20797731

Thalamic morphology in schizophrenia and schizoaffective disorder.

Matthew J Smith1, Lei Wang, Will Cronenwett, Daniel Mamah, Deanna M Barch, John G Csernansky.   

Abstract

BACKGROUND: Biomarkers are needed that can distinguish between schizophrenia and schizoaffective disorder to inform the ongoing debate over the diagnostic boundary between these two disorders. Neuromorphometric abnormalities of the thalamus have been reported in individuals with schizophrenia and linked to core features of the disorder, but have not been similarly investigated in individuals with schizoaffective disorder. In this study, we examine whether individuals with schizoaffective disorder have a pattern of thalamic deformation that is similar or different to the pattern found in individuals with schizophrenia.
METHOD: T1-weighted magnetic resonance images were collected from individuals with schizophrenia (n = 47), individuals with schizoaffective disorder (n = 15), and controls (n = 42). Large-deformation, high-dimensional brain mapping was used to obtain three-dimensional surfaces of the thalamus. Multiple analyses of variance were used to test for group differences in volume and measures of surface shape.
RESULTS: Individuals with schizophrenia or schizoaffective disorder have similar thalamic volumes. Thalamic surface shape deformation associated with schizophrenia suggests selective involvement of the anterior and posterior thalamus, while deformations in mediodorsal and ventrolateral regions were observed in both groups. Schizoaffective disorder had distinct deformations in medial and lateral thalamic regions.
CONCLUSIONS: Abnormalities distinct to schizoaffective disorder suggest involvement of the central and ventroposterior medial thalamus which may be involved in mood circuitry, dorsolateral nucleus which is involved in recall processing, and the lateral geniculate nucleus which is involved in visual processing.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797731      PMCID: PMC2996474          DOI: 10.1016/j.jpsychires.2010.08.003

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  45 in total

1.  Motor control in basal ganglia circuits using fMRI and brain atlas approaches.

Authors:  Stéphane Lehéricy; Eric Bardinet; Leon Tremblay; Pierre-Francois Van de Moortele; Jean-Baptiste Pochon; Didier Dormont; Dae-Shik Kim; Jerome Yelnik; Kamil Ugurbil
Journal:  Cereb Cortex       Date:  2005-04-27       Impact factor: 5.357

2.  A MORPHOLOGICAL STUDY OF THE LATERAL GENICULATE BODY.

Authors:  W E Clark
Journal:  Br J Ophthalmol       Date:  1932-05       Impact factor: 4.638

Review 3.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

4.  Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder.

Authors:  W Byne; M S Buchsbaum; E Kemether; E A Hazlett; A Shinwari; V Mitropoulou; L J Siever
Journal:  Arch Gen Psychiatry       Date:  2001-02

5.  Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

Authors:  S M Lawrie; H Whalley; J N Kestelman; S S Abukmeil; M Byrne; A Hodges; J E Rimmington; J J Best; D G Owens; E C Johnstone
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

6.  The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics.

Authors:  B Pakkenberg
Journal:  Schizophr Res       Date:  1992-07       Impact factor: 4.939

7.  Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.

Authors:  Matthew J Smith; Deanna M Barch; John G Csernansky
Journal:  Schizophr Res       Date:  2008-09-10       Impact factor: 4.939

8.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

9.  Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia.

Authors:  Erin A Hazlett; Monte S Buchsbaum; Eileen Kemether; Rachel Bloom; Jimcy Platholi; Adam M Brickman; Lina Shihabuddin; Cheuk Tang; William Byne
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

Review 10.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

View more
  27 in total

1.  First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.

Authors:  Kjetil N Jørgensen; Ragnar Nesvåg; Sindre Gunleiksrud; Andrea Raballo; Erik G Jönsson; Ingrid Agartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-07       Impact factor: 5.270

2.  Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder.

Authors:  Fay Y Womer; Lei Wang; Kathryn I Alpert; Matthew J Smith; John G Csernansky; Deanna M Barch; Daniel Mamah
Journal:  Psychiatry Res       Date:  2014-06-06       Impact factor: 3.222

3.  A comparative analysis of mouse and human medial geniculate nucleus connectivity: a DTI and anterograde tracing study.

Authors:  Orion P Keifer; David A Gutman; Erin E Hecht; Shella D Keilholz; Kerry J Ressler
Journal:  Neuroimage       Date:  2014-10-23       Impact factor: 6.556

4.  Northwestern University schizophrenia data sharing for SchizConnect: A longitudinal dataset for large-scale integration.

Authors:  Alex Kogan; Kathryn Alpert; Jose Luis Ambite; Daniel S Marcus; Lei Wang
Journal:  Neuroimage       Date:  2015-06-16       Impact factor: 6.556

5.  Thalamic shape and connectivity abnormalities in children with attention-deficit/hyperactivity disorder.

Authors:  Shugao Xia; Xiaobo Li; Ariane E Kimball; Mary S Kelly; Iris Lesser; Craig Branch
Journal:  Psychiatry Res       Date:  2012-11-11       Impact factor: 3.222

6.  Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat.

Authors:  Rainer Wolf; Henrik Dobrowolny; Sven Nullmeier; Bernhard Bogerts; Herbert Schwegler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-30       Impact factor: 5.270

7.  Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia.

Authors:  Derin J Cobia; Matthew J Smith; Ilse Salinas; Charlene Ng; Mokhtar Gado; John G Csernansky; Lei Wang
Journal:  Schizophr Res       Date:  2016-09-07       Impact factor: 4.939

8.  Thalamocortical connectivity during resting state in schizophrenia.

Authors:  Carsten M Klingner; Kerstin Langbein; Maren Dietzek; Stefan Smesny; Otto W Witte; Heinrich Sauer; Igor Nenadic
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-27       Impact factor: 5.270

9.  Brain gray matter phenotypes across the psychosis dimension.

Authors:  Elena I Ivleva; Anup S Bidesi; Binu P Thomas; Shashwath A Meda; Alan Francis; Amanda F Moates; Bradley Witte; Matcheri S Keshavan; Carol A Tamminga
Journal:  Psychiatry Res       Date:  2012-10-30       Impact factor: 3.222

10.  Volumetric and Shape Analysis of the Subcortical Regions in Schizophrenia Patients: A Pilot Study.

Authors:  Abdullah Abu Jamea; Muhammed Alblowi; Jamaan Alghamdi; Fahad D Alosaimi; Fahad Al-Bader; Shahid Bashir
Journal:  J Clin Imaging Sci       Date:  2019-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.